The primary purpose of the vice president for the Battelle/Ohio State collaboration is helping with “idea generation, development and implementation” and to create a “more robust” set of joint research and economic development ventures.

A couple of Midwest biomedical companies announced new venture financing this week. Could the deep freeze for early-stage investments be thawing?

Recession, economic stimulus, a new administration and globalization have changed the research and development funding picture so much this year, that R&D Magazine and Battelle updated their closely watched forecast for the first time ever.

A report authored by Battelle shows that American students are focused enough on biotech and other sciences. But wWhat’s illuminating, though, is how much has been tried to increase interest in science, the evidence of what is going right, what’s worth scrapping and what’s worth paying for.

Optivair LLC will use research on electrohydrodynamic technology (EHD) developed from the the non-profit research giant Battelle. EHD converts electrical energy into kinetic energy to more efficiently and evenly deposit drugs throughout patients’ lungs. Researchers at Battelle think it could supplant intravenous delivery for some medications.

Health science is big business. And Battelle, the Columbus research institution, is involved in health science in a big way, according to the Columbus Dispatch.

Pfizer-Wyeth fallout: At a time when many small biotech companies are desperate for cash, neither Pfizer nor Wyeth will be able to enter into new deals anytime soon.